News
Latest Newsletter, December 2023
Please find the latest news on IOIBD in the attachd PDF Newsletter. Enjoy reading, keep safe and be well. Iris Dotan, chair IOIBD 19. IOIBD Newsletter December 2023
Latest Newsletter IOIBD Summer 2023
We are happy to share the latest news on IOIBD - a vibrant society with global membership of top scientists and leading industry in IBD. Newsletter Summer 2023 We will start the registration process...
Stride-II listed as Top 10 Most Cited Articles Gastro
Congratulations Dan Turner, Axel Dignass and team! A great IOIBD collaboration and a very important project. Listed as Top 10 Cited Articles in Gastro. PIIS0016508520355724 - publication Gastro...
Future meeting dates and venues & adjusted meeting format (April 2023)
At our last IOIBD Annual General Meeting, in Cambridge (UK), the next two venues have been voted and approved by the membership: Thursday 11-Sunday 14 April 2024 Florence (Italy) Thursday 27-Sunday...
The IOIBD Clinical Experience Exchange to foster investigative career in IBD
IOIBD clinical experience exchange program The IOIBD Clinical Experience Exchange to foster investigative career in IBD We are very pleased to announce that IOIBD will operate a 3-year program under...
IOIBD New Member Profile out now!
Our newly appointed Nominating Committee chaired by Maria Abreu, with members Axel Dignass, Uma Mahadevan and Willem Bemelman, has started off in April this year. Their first assignment has...
Sad news: Our dear friend and colleague Burton Korelitz passed away
Dr. Burton I. Korelitz 30 June 1926 - 08 January 2022 It is with great sadness that we share the news that Dr. Burton I. Korelitz passed away on 08 January 2022. His lovely partner in life Ann Hanff...
Out now: Leading article in GUT SARS-CoV-2 vaccination for patients with IBD, recommendation from an international consensus meeting
SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting gutjnl-2020-324000.full
STRIDE-II Announcement
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic...
SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting
Leading article in GUT out now! gutjnl-2020-324000.full The COVID-19 pandemic has claimed the lives of nearly 2 million people worldwide.1 Following rapid sequencing of SARS-CoV-2, pharmaceutical...
COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients
Special Issue JCC Journal on Covid-19 and IBD - a collaborative work of IOIBD and ECCO. https://academic.oup.com/ecco-jcc/issue/14/Supplement_3 Providing guidance during a global viral pandemic for...
SECURE-IBD COVID-19 update #18
A second wave of COVID-19 is experienced in many countries. As of October 27, 2020, a total of 2,797 COVID-19 cases in IBD patients were reported in SECURE-IBD, paralleling this rise in COVID-19....
Contact
IOIBD Scientific Secretariat
Call Us
+31 35 5426745
Email Us
info@ioibd.org
Our Location
3742 CN Baarn
The Netherlands